MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Functional Capacity in patients with Parkinson’s Disease are related to advanced glycation end-products

    JEN. Almeida, NAT. Luna, ROD. Iborra, ANG. Alonso, ADR. -Lima (São Paulo, Brazil)

    Objective: This study aimed to estimate the AGE consumption and formation in individuals with Parkinson's disease and to relate them with their functional capacity. Background:…
  • 2019 International Congress

    Parkinson’s Disease Correlates with Reduced Risk of Hypertension

    S. Khakimova, KH. Daminova (Tashkent, Uzbekistan)

    Objective: The aim of the present study was to assess the prevalence of hypertension according to the duration of PD.The aim of the present study…
  • 2019 International Congress

    Central Insulin Resistance Index is Independent of Peripheral Insulin Resistance in Parkinson’s disease

    M. Tagliati, E. Hogg, T. Wu, K. Makwana, H. Maghzi, A. Garland, E. Tan, C. Riera (Los Angeles, CA, USA)

    Objective: To correlate brain insulin signalling with peripheral insulin resistance using neuronally derived blood exosomes in patients with Parkinson's Disease (PD) Background: Insulin signaling abnormalities may…
  • 2019 International Congress

    Can Safinamide Help to Stabilize Dopaminergic Treatment in Parkinson’s Disease?

    B. Solano Vila, A. Cots Foraster, M. Montserrat Roses (Girona, Spain)

    Objective: After more than two years of clinical experience with safinamide  we want to retrospectively review its utility as a levodopa saver in our Parkinson's…
  • 2019 International Congress

    Prevalence of advanced Parkinson’s Disease in patients treated in the hospitals of the Spanish public health care system: PARADISE Study (interim analysis)

    JC. Martínez-Castrillo, P. Martínez-Martín, A. Burgos, G. Arroyo, N. García, MR. Luquín, JM. Arbelo (Las Palmas, Spain)

    Objective: To determine the annual prevalence of patients with advanced Parkinson’s disease (APD) in patients diagnosed of Parkinson’s disease (PD) in the hospitals of the…
  • 2019 International Congress

    Knowledge, Attitude and Practices about Movement Disorders in India

    B. Shetty, S. Mittal, P. Kukkle (Bangalore, India)

    Objective: To understand the Knowledge about various Movement Disorders (MD) in general public and in various Movement Disorder Patients subgroups Background: The incidence of movement…
  • 2019 International Congress

    Relationship between serum uric acid and the pattern of striatal dopamine depletion in De Novo Parkinson’s disease

    K. Baik, Y. Lee, S. Chung, H. Yoo, J. Jung, P. Lee (Seoul, Republic of Korea)

    Objective: To investigate the relationship between serum uric acid (UA) and the pattern of striatal dopamine depletion in drug naïve Parkinson’s disease (PD). Background: UA…
  • 2019 International Congress

    Directional stimulation for Dystonic tremor

    I. Aviles-Olmos, M. Alegre, J. Artieda, J. Guridi, M. Rodriguez-Oroz (Pamplona, Spain)

    Objective: Is our aim to present our experience with bilateral directional thalamic DBS for DT. Background: Dystonic tremor(DT) is characterized by coexisting tremor and abnormal…
  • 2019 International Congress

    Does the magnitude of improvement of UPDRS III at the preoperative L-dopa test predict the degree of medication decrease one year after subthalamic nucleus Deep Brain Stimulation?

    A. Fredricks, G-M. Hariz, J. Linder, L. Eriksson, L. Forsgren, M. Hariz, P. Blomstedt (Umea, Sweden)

    Objective: To investigate whether the magnitude of improvement in motor scores of the Unified Parkinson´s Disease Rating Scale (UPDRS III) at the preoperative L-dopa challenge…
  • 2019 International Congress

    The origin of stimulation-induced dysarthria in ET patients after VIM/PSA-DBS: Atactic, spastic or both?

    H. Jergas, J. Petry-Schmelzer, J. Becker, T. Thies, J. Steffen, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)

    Objective: To investigate the origin of stimulation-induced dysarthria (SID) in essential tremor (ET) patients with bilateral deep brain stimulation (DBS) in the ventral intermediate nucleus…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley